Home
Forums
New posts
Search forums
What's new
New posts
Latest activity
Members
Current visitors
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Brown Cafe Community Center
Current Events
Early Use of Hydroxychloroquine Linked to Lower Hospitalization Rates
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Old Man Jingles" data-source="post: 4623390" data-attributes="member: 18222"><p><a href="https://link.springer.com/article/10.1007/s12035-020-02093-z" target="_blank"><span style="font-size: 26px"><strong>Effects of Antimalarial Drugs on Neuroinflammation</strong></span></a></p><p><a href="https://link.springer.com/article/10.1007/s12035-020-02093-z" target="_blank"><span style="font-size: 26px"><strong>Potential Use for Treatment of COVID-19-Related Neurologic Complications</strong></span></a></p><p></p><p>Antimalarials have unique properties that distinguish them from other anti-inflammatory drugs. (A) They are very lipophilic, which enhances their ability to cross the blood-brain barrier (BBB). Hence, they have the potential to act not only in the periphery but also in the CNS, and could be a useful addition to our limited armamentarium against the SARS-CoV-2 virus. (B) They are non-selective inhibitors of phospholipase A2 isoforms, including cytosolic phospholipase A2 (cPLA2). The latter is not only activated by cytokines but itself generates arachidonic acid, which is metabolized by cyclooxygenase (COX) to pro-inflammatory eicosanoids. Free radicals are produced in this process, which can lead to oxidative damage to the Central Nervous System.</p></blockquote><p></p>
[QUOTE="Old Man Jingles, post: 4623390, member: 18222"] [URL='https://link.springer.com/article/10.1007/s12035-020-02093-z'][SIZE=7][B]Effects of Antimalarial Drugs on Neuroinflammation Potential Use for Treatment of COVID-19-Related Neurologic Complications[/B][/SIZE][/URL] Antimalarials have unique properties that distinguish them from other anti-inflammatory drugs. (A) They are very lipophilic, which enhances their ability to cross the blood-brain barrier (BBB). Hence, they have the potential to act not only in the periphery but also in the CNS, and could be a useful addition to our limited armamentarium against the SARS-CoV-2 virus. (B) They are non-selective inhibitors of phospholipase A2 isoforms, including cytosolic phospholipase A2 (cPLA2). The latter is not only activated by cytokines but itself generates arachidonic acid, which is metabolized by cyclooxygenase (COX) to pro-inflammatory eicosanoids. Free radicals are produced in this process, which can lead to oxidative damage to the Central Nervous System. [/QUOTE]
Insert quotes…
Verification
Post reply
Home
Forums
Brown Cafe Community Center
Current Events
Early Use of Hydroxychloroquine Linked to Lower Hospitalization Rates
Top